DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
B••• C••••
Healthcare & Pharmaceuticalsgroup grade Aon a schedule nowsponsor unattributed
Also written as: B••• C•••• 2025
Principal held
at least $1.7M
sum of BDC pieces, a lower bound
Fair value
$1.6M
100c on cost, debt pieces
Unfunded
n/a
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
3
0 equity pieces beside them
Next maturity
Jan 21, 2031
no dated debt inside 24 months
On the tape since
Dec 31, 2022
latest Jun 30, 2026
Events
6
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $1.6M | 100c | SOFR+500 bp | Jan 21, 2031 | 1 |
| first lien revolver first lien | at least $5,682 | n/a | SOFR+500 bp | Jan 21, 2031 | 1 |
| first lien delayed draw term loan first lien exited Dec 31, 2024 | unknown | n/a | SOFR+500 bp | Jan 21, 2031 | 1 |
Lenders
every BDC piece at the latest quarter end
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| A•••• C••••• B•• I••• | revolver first lien Investment T••• 1st L••• R••••••• I•••• S+ S••••• 4.50% I••••••• R••• 8.73% A••••••••• D•• | $5,682 | $5,668 100c | SOFR+500 bp |
| A•••• C••••• B•• I••• | term loan first lien Investment T••• 1st L••• T••• L••• I•••• S+ S••••• 5.00% I••••••• R••• 8.73% A••••••••• D• | $1.6M | $1.6M 100c | SOFR+500 bp |
| A•••• C••••• B•• I••• | revolver first lien Investment T••• S••••• S•••••• R•••••••• L••• I•••• S+ S••••• 5.00% I••••••• R••• 8.68% M• | n/a | n/a | SOFR+500 bp |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 1 | $1.7M | $1.6M | 100c | 0 |
| Mar 31, 2026 | 1 | $1.7M | $1.7M | 100c | 0 |
| Dec 31, 2025 | 1 | $1.8M | $1.8M | 99c | 0 |
| Sep 30, 2025 | 1 | $1.7M | $1.6M | 100c | 0 |
| Jun 30, 2025 | 1 | $1.7M | $1.7M | 101c | 0 |
| Mar 31, 2025 | 1 | $1.7M | $1.7M | 101c | 0 |
| Dec 31, 2024 | 1 | $3.4M | $3.4M | 100c | 0 |
| Sep 30, 2024 | 1 | $1.7M | $1.7M | 100c | 0 |
| Jun 30, 2024 | 1 | $1.7M | $1.7M | 100c | 0 |
| Mar 31, 2024 | 1 | $1.7M | $1.7M | 100c | 0 |
| Dec 31, 2023 | 1 | $3.4M | $3.3M | 100c | 0 |
| Sep 30, 2023 | 1 | $1.7M | $1.6M | 99c | 0 |
| Jun 30, 2023 | 1 | $1.7M | $1.6M | 99c | 0 |
| Dec 31, 2022 | 1 | $1.5M | $1.5M | 100c | 0 |
What changed
- Maturity extended (observed)Dec 31, 2024
- Maturity extended (observed)Dec 31, 2024
- Maturity extended (observed)Dec 31, 2024
- Maturity extended (observed)Dec 31, 2024
- Facility left every BDC scheduleDec 31, 2024
- Maturity extended (observed)Dec 31, 2024
- Maturity extended (observed)Dec 31, 2024
- Maturity shortened (observed)Mar 31, 2024
- Maturity shortened (observed)Mar 31, 2024
- Maturity extended (observed)Dec 31, 2023
- Maturity extended (observed)Dec 31, 2023
- Maturity extended (observed)Dec 31, 2023
- Maturity extended (observed)Dec 31, 2023
- Spread increasedSep 30, 2023
- Spread increasedSep 30, 2023
- Spread increasedSep 30, 2023
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- B••• C••••derivedthe codename stem after legal suffixes and deal words
- Spellings
- 2 across 1 BDCderived
- Industry
- Healthcare & Pharmaceuticalsreportedas one filer wrote it